Medex CRO is a Türkiye-based Contract Research Organization supporting pharmaceutical, biotechnology and medical device companies with clinical research across study phases and therapeutic areas. Working with global sponsors, the company aims to deliver predictable, high-quality trial execution through structured planning, regulatory expertise and close investigator engagement. Its physician-led model places medical and scientific oversight at the centre of study management, supporting participant safety, endpoint integrity and inspection readiness.

Medex CRO’s services cover the clinical study lifecycle, from scientific and clinical strategy, protocol and study design support, and feasibility assessments to regulatory and ethics submissions in Türkiye, site start-up, clinical operations and monitoring. The company also provides data management, biostatistics oversight, pharmacovigilance support, study close-out and reporting. Its investigator and site network informs recruitment projections and enrollment planning, while proactive oversight helps manage timelines, budgets and operational risks. Medex CRO emphasizes transparent communication, defined accountability and quality systems, and reports ISO 9001 and ISO 27001 certification. Its work connects Türkiye’s clinical research capabilities with the needs of sponsors conducting studies internationally.